Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sudden death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB FR-AFSSAPS-RE20210233. An 87-year-old male patient received first dose of BNT162B2 (COMIRNATY, batch/lot number: EJ6788) intramuscularly in the right arm on 29Jan2021 at single dose for covid-19 immunisation. Medical history included chronic renal failure, chronic obstructive pulmonary disease, insulin-requiring type 2 diabetes mellitus (Insulin-dependent diabetes), atrial fibrillation, sleep apnoea syndrome, hypertension arterial, aortic prosthesis. Before vaccination, the patient complained of constipation, but stool in the evening. The patient''s concomitant medications were not reported. Patient was considered to be at risk of developing a severe form of the disease COVID-19, not having contracted COVID-19 and not being tested. First vaccination with BNT162B2 in the right arm on 29Jan2021. After the vaccination, watched by her daughter during the day, at her home. Nothing to report, no clinical signs. Sudden death of the patient occurred at 14:00 on 30Jan2021, at his home noted by the caregiver. The patient died on 30Jan2021. Cause of death reported as sudden death. It was not reported if an autopsy was performed. Outcome is fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166